Financial Performance - The company's operating revenue for Q3 2022 was CNY 230.93 million, a decrease of 7.82% compared to the same period last year[5]. - Net profit attributable to shareholders for Q3 2022 reached CNY 195.90 million, an increase of 1,381.39% year-on-year[5]. - Basic earnings per share for Q3 2022 was CNY 0.38, reflecting a significant increase of 1,366.67% compared to the previous year[5]. - Total operating revenue for the third quarter was ¥572,261,800.05, a decrease of 26.5% compared to ¥778,715,206.97 in the same period last year[19]. - The net profit for Q3 2022 was approximately ¥133 million, compared to ¥45.5 million in Q3 2021, representing a significant increase of 192%[20]. - The total comprehensive income for Q3 2022 was approximately ¥133 million, compared to ¥45.5 million in Q3 2021[20]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,834.60 million, a decrease of 1.51% from the previous year-end[5]. - The company’s total assets decreased to ¥1,801,239,243.01 from ¥1,828,855,610.04, a decline of 1.5%[17]. - Total liabilities decreased to ¥1,315,616,375.16, down 11.6% from ¥1,487,473,228.26[17]. - The company’s cash and cash equivalents at the end of Q3 2022 amounted to approximately ¥108.8 million, up from ¥74.7 million at the end of Q3 2021[22]. Cash Flow - The company's cash flow from operating activities for the year-to-date was CNY 96.15 million, an increase of 219.46% compared to the same period last year[5]. - The net cash flow from operating activities increased by 219.46% to ¥96,148,574.83, driven by decreased cash payments for goods and services[11]. - The operating cash flow for Q3 2022 was approximately ¥96.1 million, an increase from ¥30.1 million in the same period last year[21]. - The cash inflow from operating activities totaled approximately ¥691 million, while cash outflow was approximately ¥594.9 million, resulting in a net cash inflow[21]. - The company reported a net cash flow from financing activities of approximately ¥10.5 million, compared to a net outflow of ¥105.1 million in Q3 2021[22]. Investments and Expenses - The company’s investment properties increased by 88.44% to CNY 69.67 million, attributed to leasing out gas stations[10]. - Research and development expenses fell by 71.88% to ¥543,215.59, indicating a reduction in R&D investments[11]. - Sales expenses decreased by 32.87% to ¥103,121,314.94, primarily due to reduced personnel and marketing investments impacted by the pandemic[11]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 56,905[12]. - The largest shareholder, Guangzheng Investment Co., Ltd., holds 25.06% of the shares, totaling 129,168,708 shares[12]. Other Financial Metrics - The company reported a total of CNY 212.38 million in non-recurring gains and losses for the reporting period[7]. - The company reported a significant increase in other income, up 107,553.70% to ¥212,467,519.58, due to a court ruling regarding a previous equity payment[11]. - The company experienced a 100% decrease in trading financial assets, dropping to CNY 0.00, primarily due to the redemption of financial products[10]. - The company’s contract assets rose by 53.81% to CNY 22.83 million, due to increased receivables from completed projects[10]. - Contract liabilities increased significantly by 635.40% to ¥79,006,073.42, attributed to an increase in contract prepayments[11].
光正眼科(002524) - 2022 Q3 - 季度财报